↓ Skip to main content

Dove Medical Press

Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?

Overview of attention for article published in ImmunoTargets and Therapy, January 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)

Mentioned by

news
2 news outlets

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
33 Mendeley
Title
Alzheimer’s disease and immunotherapy: what is wrong with clinical trials?
Published in
ImmunoTargets and Therapy, January 2015
DOI 10.2147/itt.s49923
Pubmed ID
Authors

Kuniko Kohyama, Yoh Matsumoto

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 15%
Student > Ph. D. Student 5 15%
Researcher 5 15%
Other 2 6%
Student > Master 2 6%
Other 5 15%
Unknown 9 27%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 9 27%
Neuroscience 5 15%
Agricultural and Biological Sciences 4 12%
Immunology and Microbiology 2 6%
Psychology 1 3%
Other 1 3%
Unknown 11 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2023.
All research outputs
#2,921,950
of 25,748,735 outputs
Outputs from ImmunoTargets and Therapy
#1
of 1 outputs
Outputs of similar age
#38,710
of 361,607 outputs
Outputs of similar age from ImmunoTargets and Therapy
#1
of 1 outputs
Altmetric has tracked 25,748,735 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.0. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,607 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them